These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28379437)

  • 1. Sex as a biological variable in response to temozolomide.
    Russell L; Bolyard C; Banasavadi-Siddegowda Y; Weiss A; Zhang J; Shakya R; Powell K; Kaur B
    Neuro Oncol; 2017 Jun; 19(6):873-874. PubMed ID: 28379437
    [No Abstract]   [Full Text] [Related]  

  • 2. Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma.
    Gholamin S; Youssef OA; Rafat M; Esparza R; Kahn S; Shahin M; Giaccia AJ; Graves EE; Weissman I; Mitra S; Cheshier SH
    Innate Immun; 2020 Feb; 26(2):130-137. PubMed ID: 31547758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-Based Practice: Temozolomide Beyond Glioblastoma.
    Chua J; Nafziger E; Leung D
    Curr Oncol Rep; 2019 Mar; 21(4):30. PubMed ID: 30835007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition.
    Liu T; Li A; Xu Y; Xin Y
    Oncol Rep; 2019 Mar; 41(3):1883-1892. PubMed ID: 30664175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.
    Nickel AC; Wan XY; Saban DV; Weng YL; Zhang S; Keyvani K; Sure U; Zhu Y
    J Neurooncol; 2019 Jan; 141(1):31-41. PubMed ID: 30392087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide for immunomodulation in the treatment of glioblastoma.
    Karachi A; Dastmalchi F; Mitchell DA; Rahman M
    Neuro Oncol; 2018 Nov; 20(12):1566-1572. PubMed ID: 29733389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma in elderly patients: solid conclusions built on shifting sand?
    Wick A; Kessler T; Elia AEH; Winkler F; Batchelor TT; Platten M; Wick W
    Neuro Oncol; 2018 Jan; 20(2):174-183. PubMed ID: 29016815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity.
    Zhang D; Dai D; Zhou M; Li Z; Wang C; Lu Y; Li Y; Wang J
    Cell Physiol Biochem; 2018; 51(6):2496-2508. PubMed ID: 30562739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma.
    Chamberlain MC; Chalmers L
    J Neurooncol; 2007 Apr; 82(2):207-9. PubMed ID: 17019532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
    Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W
    J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Non-narcotic Opium Alkaloid Papaverine Suppresses Human Glioblastoma Cell Growth.
    Inada M; Sato A; Shindo M; Yamamoto Y; Akasaki Y; Ichimura K; Tanuma SI
    Anticancer Res; 2019 Dec; 39(12):6743-6750. PubMed ID: 31810939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study.
    Fabbro-Peray P; Zouaoui S; Darlix A; Fabbro M; Pallud J; Rigau V; Mathieu-Daude H; Bessaoud F; Bauchet F; Riondel A; Sorbets E; Charissoux M; Amelot A; Mandonnet E; Figarella-Branger D; Duffau H; Tretarre B; Taillandier L; Bauchet L
    J Neurooncol; 2019 Mar; 142(1):91-101. PubMed ID: 30523606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
    Huang S; Qi P; Zhang T; Li F; He X
    Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of the long-term use of temozolomide for treating newly diagnosed glioblastoma in Germany.
    Waschke A; Arefian H; Walter J; Hartmann M; Maschmann J; Kalff R
    J Neurooncol; 2018 Jun; 138(2):359-367. PubMed ID: 29468446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems.
    Toren A; Pismenyuk T; Yalon M; Freedman S; Simon AJ; Fisher T; Moshe I; Reichardt JK; Constantini S; Mardor Y; Last D; Guez D; Daniels D; Assoulin M; Mehrian-Shai R
    Oncotarget; 2016 Nov; 7(46):74860-74871. PubMed ID: 27556862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model.
    Fujihara T; Mizobuchi Y; Nakajima K; Kageji T; Matsuzaki K; Kitazato KT; Otsuka R; Hara K; Mure H; Okazaki T; Kuwayama K; Nagahiro S; Takagi Y
    J Neurooncol; 2018 Sep; 139(2):323-332. PubMed ID: 29779087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of an optimal dosing schedule for combining Irinophore C™ and temozolomide in an orthotopic model of glioblastoma.
    Verreault M; Wehbe M; Strutt D; Masin D; Anantha M; Walker D; Chu F; Backstrom I; Kalra J; Waterhouse D; Yapp DT; Bally MB
    J Control Release; 2015 Dec; 220(Pt A):348-357. PubMed ID: 26528901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase D1 inhibition sensitizes glioblastoma to temozolomide and suppresses its tumorigenicity.
    Kang DW; Hwang WC; Noh YN; Park KS; Min DS
    J Pathol; 2020 Nov; 252(3):304-316. PubMed ID: 32725633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment.
    Dirkse A; Golebiewska A; Buder T; Nazarov PV; Muller A; Poovathingal S; Brons NHC; Leite S; Sauvageot N; Sarkisjan D; Seyfrid M; Fritah S; Stieber D; Michelucci A; Hertel F; Herold-Mende C; Azuaje F; Skupin A; Bjerkvig R; Deutsch A; Voss-Böhme A; Niclou SP
    Nat Commun; 2019 Apr; 10(1):1787. PubMed ID: 30992437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.